Aug 2026· ACS Applied Bio Materials· Vol 9 17, pp.
8030-8043
· 0 citations· 36 references
Medicine
TL;DR
An intelligent nanoplatform-GOD-Fe3+&DOX-Membrane@Polymer (GOD-Fe3+&DM@Poly.)-based on reversible addition-fragmentation chain transfer (RAFT) polymerization technology is constructed, establishing a valuable technical framework for the development of multifunctional and stimuli-responsive nanomedicines.
Abstract
Endometrial cancer is a common malignant tumor in the female reproductive system. Traditional chemotherapy has limitations such as poor targeting, dose-limiting toxicity, and treatment intensity restrictions. To address these issues, this study constructed an intelligent nanoplatform-GOD-Fe3+&DOX-Membrane@Polymer (GOD-Fe3+&DM@Poly.)-based on reversible addition-fragmentation chain transfer (RAFT) polymerization technology. The incorporation of pyridine disulfide bonds as polymer side chains through RAFT polymerization facilitated the precise covalent immobilization of glucose oxidase (GOD), effectively mitigating the leakage issues commonly observed with physical encapsulation methods. Concurrently, benzylboronic acid moieties were integrated into the polymer backbone, enabling the formation of reversible borate ester linkages with sialic acid residues present on the membranes of HEC-1A cancer cells. This interaction promoted homologous targeting and substantially improved their intratumoral enrichment efficiency. In addition, GOD-mediated starvation therapy and Fe3+-triggered chemodynamic therapy construct a cascade reaction: GOD consumes tumor glucose to produce H2O2, which is converted into highly toxic hydroxyl radicals through the Fe3+-mediated Fenton reaction, amplifying tumor oxidative stress to initiate ferroptosis. This integration establishes a valuable technical framework for the development of multifunctional and stimuli-responsive nanomedicines.
In vitro and in vivo evaluations confirm that R-A/G@Z effectively suppresses aggressive breast tumors while maintaining a good safety profile, offering a promising strategy for intelligent metabolic-chemodynamic cancer nanomedicine.
Nian-Ting Xiao, Xiao He, Da-Xiu Li et al.· Journal of Colloid and Inter...· 0 citations
Background Colorectal cancer therapy encounters major obstacles, including insufficient tumor targeting, systemic toxicity, and the emergence of drug resistance, underscoring the need for advanced therapeutic modalities. This work aimed to engineer a multi-mechanism synergistic nanoplatform to surmount these limitation...
Xin-Xin Zhang, Feng-Yuan Qian, Yi-Xiang Huang et al.· International Journal of Nan...· 0 citations
A dual-functional self-assembled nanoplatform integrating PDT and selective uPA inhibition for synergistic CRC treatment achieves short-term acute tumor ablation via PDT and sustained anti-metastatic potential via uPA inhibition within the tested observation windows, with favorable biosafety.
It is concluded that ZIF-8 represents a versatile platform; however, its clinical application necessitates a paradigm shift from empirical design to mechanism-driven engineering, alongside standardized scalable production.
Ru-Jia Xie, Wangxia Peng, Bo-Zhi Zeng et al.· International Journal of Nan...· 1 citation
A 5-FU covalent conjugate with the self-assembling, heterochiral tripeptide DLeu-Phe-Phe (lFF) via a redox-sensitive linker (5-FU-SS-lFF) yields supramolecular hydrogels with rheological properties similar to those of lFF hydrogels and enables 5-FU release under reducing conditions, such as those present in the tumor m...
M. Mihajlovic, Milos Mihajlovic, Paola Alletto et al.· Bioconjugate chemistry· 0 citations
Peritoneal metastasis is a leading cause of mortality in end‐stage gastric cancer and remains poorly responsive to conventional chemotherapy. To address this unmet need, Janus dendron‐modified phthalocyanines were developed as tumor‐targeted photosensitizers for photodynamic therapy (PDT). A series of Janus dendron‐mod...
Jian-Ping Guo, Shu-Jie Zhang, Zi-Jian Deng et al.· Advanced Healthcare Material...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.